Eyenovia Correlations
EYEN Stock | USD 0.11 0.02 19.05% |
The current 90-days correlation between Eyenovia and Transcode Therapeutics is 0.06 (i.e., Significant diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Eyenovia moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Eyenovia moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Eyenovia Correlation With Market
Average diversification
The correlation between Eyenovia and DJI is 0.16 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Eyenovia and DJI in the same portfolio, assuming nothing else is changed.
Eyenovia |
Moving together with Eyenovia Stock
0.63 | VALN | Valneva SE ADR Downward Rally | PairCorr |
0.83 | DNTH | Dianthus Therapeutics | PairCorr |
0.82 | DRRX | Durect | PairCorr |
0.64 | VIGL | Vigil Neuroscience | PairCorr |
0.7 | VIRX | Viracta Therapeutics | PairCorr |
0.67 | VTGN | VistaGen Therapeutics | PairCorr |
0.69 | EDIT | Editas Medicine | PairCorr |
0.72 | VXRT | Vaxart Inc | PairCorr |
Moving against Eyenovia Stock
0.43 | VERA | Vera Therapeutics | PairCorr |
0.42 | VCEL | Vericel Corp Ord | PairCorr |
0.35 | SABSW | SAB Biotherapeutics | PairCorr |
0.59 | VTRS | Viatris | PairCorr |
0.54 | ELTX | Elicio Therapeutics | PairCorr |
0.44 | VSTM | Verastem | PairCorr |
0.41 | VRNA | Verona Pharma PLC | PairCorr |
0.36 | ENSC | Ensysce Biosciences | PairCorr |
0.32 | VYNE | Vyne Therapeutics | PairCorr |
Related Correlations Analysis
0.68 | -0.08 | 0.34 | -0.19 | -0.05 | ZVSA | ||
0.68 | 0.03 | 0.55 | -0.22 | -0.02 | SONN | ||
-0.08 | 0.03 | 0.25 | 0.54 | 0.29 | ZURA | ||
0.34 | 0.55 | 0.25 | 0.14 | -0.14 | PHIO | ||
-0.19 | -0.22 | 0.54 | 0.14 | -0.03 | RNAZ | ||
-0.05 | -0.02 | 0.29 | -0.14 | -0.03 | QNRX | ||
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Eyenovia Stock performing well and Eyenovia Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Eyenovia's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ZVSA | 4.67 | (0.99) | 0.00 | 0.60 | 0.00 | 9.17 | 78.93 | |||
SONN | 4.76 | (0.77) | 0.00 | 2.19 | 0.00 | 12.31 | 37.58 | |||
ZURA | 3.78 | (0.36) | 0.00 | (0.09) | 0.00 | 7.95 | 30.69 | |||
PHIO | 4.53 | (0.30) | 0.00 | (0.18) | 0.00 | 11.78 | 36.22 | |||
RNAZ | 7.63 | 1.05 | 0.10 | (0.44) | 6.52 | 22.00 | 68.80 | |||
QNRX | 6.21 | 0.47 | 0.07 | 0.37 | 6.73 | 17.65 | 74.46 |
Eyenovia Corporate Management
Andrew Jones | Chief Officer | Profile | |
Bren Kern | VP Operations | Profile | |
Tony Cardinale | Vice Sales | Profile | |
Norbert Lowe | Senior Operations | Profile | |
Alexander Lobo | Investor Contact | Profile | |
MD MPH | President, CoFounder | Profile |